Physician profile
Fred Usoh
NPI 1821277443
$2,176.95
in general payments reported to CMS, 2019-2025
16 companies · $519 in 2025
The $519 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $226 · 2021: $134 · 2022: $329 · 2023: $237 · 2024: $341 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $901.14 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Infinion 16 |
| Collegium Pharmaceutical, INC. | $296.96 | 2020-2025 | Belbuca, Xtampza |
| Grt US Holding, INC. | $173.93 | 2022 | |
| Medtronic USA, INC. | $120.27 | 2019-2020 | |
| Globus Medical, INC. | $114.26 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $110.72 | 2019-2021 | |
| Averitas Pharma INC. | $109.55 | 2023-2025 | Qutenza |
| Vertos Medical, INC. | $100.28 | 2022-2023 | Mild Device Kit |
| Si-Bone, INC. | $97.89 | 2019-2024 | |
| Biotronik Nro, INC. | $36.38 | 2025 | Prospera |
| Ibsa Pharma INC. | $33.95 | 2020-2021 | |
| Bioventus LLC | $23.57 | 2024 | Stimrouter Implantable Kit |
| Novus Surgical Consultants | $17.39 | 2022 | |
| Avanos Medical | $14.66 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.50 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Usoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.